Higher vitamin D levels tied to fewer hospitalization for respiratory tract infections

	Pulmonology
	The latest pulmonology news from News Medical

	Higher vitamin D levels tied to fewer hospitalization for respiratory tract infections Severe vitamin D deficiency is associated with a higher rate of hospitalization for respiratory tract infections such as bronchitis and pneumonia, according to a new study led by the University of Surrey.

	More iron, less damage: why chronic lung infections persist Research shows that iron-rich conditions boost Pseudomonas aeruginosa growth and biofilm formation, yet reduce virulence, complicating chronic lung infections.

			Blood lipid–hormone ratios predict future asthma attacks years in advance This study shows that specific ratios of circulating sphingolipids to steroids can predict the risk of future asthma exacerbations over five years with high discriminatory performance. By integrating metabolomics with longitudinal medical records, the research highlights lipid–hormone pathway imbalance as a key driver of asthma instability.

			Newly discovered survival pathway explains stubborn EGFR-driven lung cancers Scientists from ASTAR Institute of Molecular and Cell Biology (ASTAR IMCB) have identified why certain lung cancer cells become highly resistant to treatment after developing mutations in a key gene called EGFR (epidermal growth factor receptor).

			Pandemic linked to lasting drops in diagnosis rates for major conditions There has been a lasting and disproportionate impact of the Covid-19 pandemic on diagnosis rates for conditions including depression, asthma and osteoporosis.

	Understanding tumor growth patterns helps guide treatment after lung cancer When lung cancer treatment stops working, what happens next? New research reveals the answer may depend on how the cancer grows.

	Bedfont® Scientific Limited is pleased to support a major milestone to improve asthma care Bedfont® Scientific Limited, a medical device manufacturer based in Kent, with over 49 years’ experience in the breath analysis industry, was pleased to support its UK distributor, Intermedical UK, in supplying the 3,000th NObreath® Fractional exhaled Nitric Oxide (FeNO) device in the UK.

	Targeted Fab fragments dismantle the allergy trigger Allergic diseases represent a major global health burden, placing significant strain on healthcare systems worldwide. Severe conditions such as anaphylaxis, asthma, food allergy, and allergic rhinitis are driven by immunoglobulin E (IgE), an antibody that binds to immune cells, including mast cells and basophils.

	Study identifies genes, smoking, and obesity as pneumonia risk factors Researchers at the University of Oulu have identified genes that increase susceptibility to pneumonia. Alongside inherited risk factors, smoking and higher body mass were also found to raise the risk of developing the disease.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2026